Cancer Plus
Electronic ISSN: 2661-3840 Print ISSN: 2661-3832
Editor-in-Chief: Xiansheng Liu View Editorial Board

Cancer Plus is a research journal dedicated to the publication of findings in cancer research.  This journal is a joint collaboration between Shanxi Academy of Medical Sciences, Shanxi Bethune Hospital (China), and the Chinese Academy of Sciences.

We encourage researchers to publish the latest findings in cancer research, including preliminary results, repeated argumentation studies and negative results. The journal welcomes various types of submissions, e.g. research papers, clinical research reports, review articles.


Role of the IL-8/CXCR2 axis in promoting vasculogenic mimicry in triple-negative breast cancer through epithelial-mesenchymal transition

Saheed Abdulkarim, Jude Tetteh Quarshie, Peggy Afua Birokorang, Mawusi Adepa Mawuli, ... Anastasia Rosebud Aikins
CP 2024, 6(2), 3356

Long non-coding RNA DARS-AS1 facilitates breast cancer progression by modulating the miR-6835-3p/ATF3 axis

Krishnamoorthy Vignesh, Pattusamy Thangamalar
CP 2024, 6(2), 2867

Role of palliative radiotherapy in cardiac metastasis: A review

Sharma Neha, Chauhan Ashok
CP 2024, 6(2), 2921

Microbial allies: Personalized probiotics and their role in tailoring cancer immunotherapies

Tanwy Chowdhury, Zarin Rushni, Hasnain Anjum, Kumkum Rahman Mouree
CP 2024, 6(2), 3289
Special Issues

Stromal Cells in the Tumor Environment

Guest Editors: Veronka Lukacs-Kornek , Jian Li
Submission deadline: 15 March 2025

Advances in Bone Metastasis Management

Guest Editor: Andrea Sambri
Submission deadline: 15 October 2024
News and Announcements
Back to top
Cancer Plus, Electronic ISSN: 2661-3840 Print ISSN: 2661-3832, Published by AccScience Publishing